01 1Ertapenem For Injection
02 2Ertapenem for Injection
03 9Invanz
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 66
2019 Revenue in Millions : 105
Growth (%) : -37
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 211
2019 Revenue in Millions : 263
Growth (%) : -20
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 202
2020 Revenue in Millions : 211
Growth (%) : -4
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 189
2021 Revenue in Millions : 202
Growth (%) : -6
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2015 Revenue in Millions : 529
2014 Revenue in Millions : 569
Growth (%) : 8%
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2014 Revenue in Millions : 8.40%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 58
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 105
2018 Revenue in Millions : 58
Growth (%) : 82
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 561
2015 Revenue in Millions : 569
Growth (%) : -1
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 602
2016 Revenue in Millions : 561
Growth (%) : 7
LOOKING FOR A SUPPLIER?
